GMF(SZ:002551) Sou Hu Cai Jing·2026-01-02 20:09Core Viewpoint - The company, Shangrong Medical, has experienced a slight decline in stock price and has held a significant shareholder meeting to approve various governance changes and the reappointment of its accounting firm [1][2][3] Group 1: Stock Performance - As of December 31, 2025, Shangrong Medical's stock closed at 3.65 yuan, down 1.35% from the previous week [1] - The stock reached a high of 3.71 yuan and a low of 3.6 yuan during the week [1] - The company's current total market capitalization is 3.086 billion yuan, ranking 104th out of 127 in the medical device sector and 4480th out of 5181 in the A-share market [1] Group 2: Shareholder Meeting Announcements - The company held its second extraordinary general meeting on December 29, 2025, where it combined on-site and online voting to approve the reappointment of the accounting firm, amendments to the company’s articles of association, and changes to governance systems [2][3] - The amendments to the articles of association and certain governance systems were special resolutions that received over two-thirds of the voting rights from attending shareholders [2] - The meeting's resolutions were deemed legally valid, supported by a legal opinion from Guangdong Huashang Law Firm [2] Group 3: Board Changes - Non-independent director and deputy general manager Zhang Jierui resigned due to internal work adjustments but will continue to hold other positions within the company [1][3] - On the same day, Zhang Jierui was elected as a representative director of the eighth board, with a term lasting until the current board's term ends [1][3] - The board remains compliant with the required number of directors, maintaining a total of nine members [1]